Fizimed has secured €4 million in funding from major investors to accelerate its international expansion in the femtech sector.

Information on the Target

Fizimed, a French femtech company established in 2017 in Strasbourg, is dedicated to revolutionizing women's health on a global scale by providing innovative products tailored to their daily needs. The company is focused on addressing significant issues related to women's health, such as motherhood, menstruation, menopause, and pelvic floor disorders, which are often shrouded in societal taboos.

Among Fizimed's flagship products are the Emy Trainer and Emy Pump. The Emy Trainer is a pelvic floor rehabilitation probe that enables women to strengthen their pelvic muscles conveniently at home. It has received acclaim from thousands of users for effectively addressing urinary incontinence, a condition affecting approximately one in three women. Clinical trials have demonstrated the efficacy of the Emy Trainer, enhancing its credibility and impact on women's health. The Emy Pump is a hands-free breast pump designed to simplify breastfeeding, providing greater freedom and comfort for new mothers.

Industry Overview in France

The femtech industry has gained significant traction in France, focusing on developing technologies and products that address the unique health needs of women. Despite considerable societal pr